T1	PROC 46 66	Estudio de seguridad
#1	AnnotatorNotes T1	C1705187; Safety Study; Research Activity
T2	PROC 71 82	tratamiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	DISO 86 90	DIPG
#3	AnnotatorNotes T3	C2986658; Diffuse Intrinsic Pontine Glioma; Neoplastic Process
T4	ANAT 95 124	células dendríticas autólogas
#4	AnnotatorNotes T4	C0879593; therapeutic autologous dendritic cells; Cell · Pharmacologic Substance
T5	DISO 145 152	tumoral
#5	AnnotatorNotes T5	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T6	PROC 185 226	Ensayo clínico fase Ib sobre la seguridad
T7	PROC 233 246	Inmunoterapia
#6	AnnotatorNotes T7	C0021083; Immunotherapy; Therapeutic or Preventive Procedure
T8	ANAT 251 280	células dendríticas autólogas
#7	AnnotatorNotes T8	C0879593; therapeutic autologous dendritic cells; Cell · Pharmacologic Substance
T9	ANAT 304 320	líneas tumorales
#8	AnnotatorNotes T9	C0085983; Cell Line, Tumor; Cell
T10	DISO 311 320	tumorales
#9	AnnotatorNotes T10	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T11	DISO 349 383	glioma intrínseco difuso de tronco
T12	ANAT 377 383	tronco
#10	AnnotatorNotes T12	C0460005; Trunk structure; Body Location or Region | C1280632; Entire trunk; Body Location or Region
T13	DISO 385 389	DIPG
#11	AnnotatorNotes T13	C2986658; Diffuse Intrinsic Pontine Glioma; Neoplastic Process
T14	DISO 414 448	Glioma intrínseco difuso de tronco
T15	ANAT 442 448	tronco
#12	AnnotatorNotes T15	C0460005; Trunk structure; Body Location or Region | C1280632; Entire trunk; Body Location or Region
T16	DISO 450 454	DIPG
#13	AnnotatorNotes T16	C2986658; Diffuse Intrinsic Pontine Glioma; Neoplastic Process
T17	PROC 499 510	diagnóstico
#14	AnnotatorNotes T17	C0011900; Diagnosis; Diagnostic Procedure
T18	DISO 523 527	DIPG
#15	AnnotatorNotes T18	C2986658; Diffuse Intrinsic Pontine Glioma; Neoplastic Process
T19	PROC 559 571	radioterapia
#16	AnnotatorNotes T19	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T20	PROC 701 710	Karnofsky
#17	AnnotatorNotes T20	C0206065; Karnofsky Performance Status; Diagnostic Procedure
T21	ANAT 791 798	medular
#18	AnnotatorNotes T21	C0376152; Marrow; Body Part, Organ, or Organ Component | C1550278; Medullary - body parts; Body Part, Organ, or Organ Component
T22	PROC 828 865	tratamiento farmacológico antitumoral
T23	PROC 935 943	aféresis
#19	AnnotatorNotes T23	C0005791; Apheresis (procedure); Therapeutic or Preventive Procedure
T24	PROC 966 986	estudio experimental
T25	PROC 1038 1061	tratamiento antitumoral
T26	DISO 1084 1096	Comorbilidad
#20	AnnotatorNotes T26	C1275743; Co-morbid conditions; Finding
T27	PROC 1119 1141	tratamiento en estudio
#21	AnnotatorNotes T27	C0949266; Therapies, Investigational; Therapeutic or Preventive Procedure
T28	DISO 1201 1224	corticoide-dependientes
T29	CHEM 1178 1190	dexametasona
#22	AnnotatorNotes T29	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T30	CHEM 1201 1211	corticoide
#23	AnnotatorNotes T30	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T31	DISO 1239 1260	enfermedad diseminada
T32	DISO 1281 1290	infección
#24	AnnotatorNotes T32	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T33	PROC 1304 1314	Serologías
#25	AnnotatorNotes T33	C0036743; Serologic tests; Laboratory Procedure
T34	DISO 1328 1331	VIH
#26	AnnotatorNotes T34	C0458074; Human immunodeficiency virus (HIV) status; Finding
T35	DISO 1333 1336	VHC
#27	AnnotatorNotes T35	C0019196; Hepatitis C; Disease or Syndrome
T36	DISO 1339 1342	VHB
#28	AnnotatorNotes T36	C0019163; Hepatitis B; Disease or Syndrome
T37	CHEM 138 152	lisado tumoral
T38	CHEM 294 320	lisado de líneas tumorales
T39	Date 13 17	2015
T40	LIVB 335 344	pacientes
#29	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	LIVB 482 491	Pacientes
#30	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	Date 511 519	reciente
T43	LIVB 528 537	Pacientes
#31	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	Duration 581 593	los 100 días
T45	Age 639 660	entre los 3 y 18 años
T46	Age 724 742	mayores de 16 años
T47	Duration 765 782	mayor a 8 semanas
T48	Neg_cue 810 812	No
T49	Date 869 882	el último mes
T50	Neg_cue 909 925	Imposibilidad de
T51	Duration 990 1012	los últimos tres meses
T52	LIVB 1013 1021	Paciente
#32	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	Duration 1062 1083	las últimas 4 semanas
T54	Neg_cue 1101 1107	impida
T55	LIVB 1142 1151	pacientes
#33	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	Dose 1166 1170	>2mg
T57	Frequency 1170 1174	/día
T58	LIVB 1191 1200	pacientes
#34	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	LIVB 1225 1234	Pacientes
#35	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	LIVB 1261 1269	Paciente
#36	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T64	PHYS 783 798	Función medular
A1	Assertion T22 Negated
A2	Assertion T23 Negated
A3	Assertion T27 Negated
A4	Status T19 History_of
A5	Status T24 History_of
A6	Status T22 History_of
#37	AnnotatorNotes T11	C2986658; Diffuse Intrinsic Pontine Glioma; Neoplastic Process
#38	AnnotatorNotes T14	C2986658; Diffuse Intrinsic Pontine Glioma; Neoplastic Process
#39	AnnotatorNotes T24	C0681814; research study; Research Activity
#40	AnnotatorNotes T42	C0332185; Recent; Temporal Concept
T61	Observation 1108 1115	tolerar
A7	Assertion T61 Negated
R1	Negation Arg1:T54 Arg2:T61	
R2	Negation Arg1:T54 Arg2:T27	
R3	Overlap Arg1:T61 Arg2:T27	
T62	CONC 745 764	Expectativa de vida
#41	AnnotatorNotes T62	C0023671; Life Expectancy; Group Attribute
R4	Has_Duration_or_Interval Arg1:T62 Arg2:T47	
R5	Location_of Arg1:T21 Arg2:T64	
T63	Observation 783 809	Función medular conservada
R6	Location_of Arg1:T21 Arg2:T63	
R7	Used_for Arg1:T4 Arg2:T2	
T65	Quantifier_or_Qualifier 153 162	alogénico
#42	AnnotatorNotes T65	C1515895; Allogeneic; Qualitative Concept
R8	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T65	
T66	Quantifier_or_Qualifier 321 331	alogénicas
#43	AnnotatorNotes T66	C1515895; Allogeneic; Qualitative Concept
R9	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T66	
R10	Used_for Arg1:T8 Arg2:T7	
T67	Quantifier_or_Qualifier 125 152	cargadas con lisado tumoral
R11	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T67	
T68	Quantifier_or_Qualifier 281 320	pulsadas con lisado de líneas tumorales
R12	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T68	
R13	Experiences Arg1:T40 Arg2:T7	
R14	Experiences Arg1:T40 Arg2:T11	
R15	Experiences Arg1:T40 Arg2:T13	
R16	Location_of Arg1:T12 Arg2:T11	
R17	Location_of Arg1:T12 Arg2:T13	
R18	Location_of Arg1:T15 Arg2:T16	
R19	Location_of Arg1:T15 Arg2:T14	
R20	Overlap Arg1:T18 Arg2:T42	
R21	Experiences Arg1:T41 Arg2:T18	
R22	Overlap Arg1:T17 Arg2:T42	
R23	Negation Arg1:T48 Arg2:T22	
R24	Overlap Arg1:T22 Arg2:T49	
R25	Negation Arg1:T50 Arg2:T23	
R26	Overlap Arg1:T24 Arg2:T51	
T69	Observation 944 986	Participación en otro estudio experimental
R27	Overlap Arg1:T69 Arg2:T51	
R28	Has_Duration_or_Interval Arg1:T25 Arg2:T53	
R29	Experiences Arg1:T52 Arg2:T25	
R30	Before Arg1:T26 Arg2:T61	
R31	Experiences Arg1:T55 Arg2:T29	
R32	Has_Frequency Arg1:T29 Arg2:T57	
R33	Has_Dose_or_Strength Arg1:T29 Arg2:T56	
R34	Experiences Arg1:T58 Arg2:T30	
R35	Experiences Arg1:T58 Arg2:T28	
#44	AnnotatorNotes T28	C0521861; Dependence on corticoids; Finding
R36	Experiences Arg1:T59 Arg2:T31	
R37	Causes Arg1:T30 Arg2:T28	
R38	Experiences Arg1:T60 Arg2:T32	
T70	Quantifier_or_Qualifier 1291 1303	incontrolada
#45	AnnotatorNotes T70	C0205318; Uncontrolled; Qualitative Concept
R39	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T70	
T71	Result_or_Value 1315 1324	positivas
#46	AnnotatorNotes T71	C1446409; Positive; Finding
R43	Has_Result_or_Value Arg1:T33 Arg2:T71	
R44	Experiences Arg1:T43 Arg2:T19	
R45	Overlap Arg1:T19 Arg2:T44	
T72	Quantifier_or_Qualifier 572 577	focal
#47	AnnotatorNotes T72	C0205234; Focal; Spatial Concept
R46	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T72	
A8	Status T72 History_of
T73	CONC 607 616	inclusión
#48	AnnotatorNotes T73	C1512693; Inclusion; Qualitative Concept
R47	Before Arg1:T19 Arg2:T73	
R48	Overlap Arg1:T20 Arg2:T46	
T74	Result_or_Value 711 714	>50
R49	Has_Result_or_Value Arg1:T20 Arg2:T74	
T75	Result_or_Value 696 699	>50
T76	CONC 669 695	Escala funcional de Lansky
#49	AnnotatorNotes T76	C1522275; Lansky Play-Performance Status; Intellectual Product 
R50	Has_Result_or_Value Arg1:T76 Arg2:T75	
R51	Experiences Arg1:T40 Arg2:T10	
#50	AnnotatorNotes T25	C0920425; cancer treatment; Therapeutic or Preventive Procedure
A9	Experiencer T40 Patient
A10	Experiencer T41 Patient
A11	Experiencer T43 Patient
A12	Experiencer T52 Patient
A13	Experiencer T55 Patient
A14	Experiencer T58 Patient
A15	Experiencer T59 Patient
A16	Experiencer T60 Patient
